IGF1/IGF1R MITOGENIC PATHWAYS AND IMPLICATIONS IN GB THERAPY

Glioblastoma (GB), the most frequent human brain cancer commonly exhibit abberant proliferation and diminished apoptosis.The neoplastic transformation of the glial cells is often related to an overexpression of growth factors and upregulation of their signaling pathways. Insulin-like growth factor 1...

Full description

Bibliographic Details
Main Authors: Oana Alexandru, Cornelia Zaharia, Valerica Tudoric, D.O. Alexandru
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2008-03-01
Series:Romanian Journal of Neurology
Subjects:
gb
Online Access:https://revistemedicale.amaltea.ro/Romanian_Journal_of_NEUROLOGY/Revista_Romana_de_NEUROLOGIE-2008-Nr.1/RJN_2008_1_Art-01.pdf
id doaj-f0fa49eddd4e465ea4d3109b73a17368
record_format Article
spelling doaj-f0fa49eddd4e465ea4d3109b73a173682020-11-25T03:53:20ZengAmaltea Medical Publishing HouseRomanian Journal of Neurology1843-81482069-60942008-03-01715910.37897/RJN.2008.1.1IGF1/IGF1R MITOGENIC PATHWAYS AND IMPLICATIONS IN GB THERAPYOana Alexandru0Cornelia Zaharia1Valerica Tudoric2D.O. Alexandru3Department of Neurology,University of Medicine and Pharmacy, CraiovaDepartment of Neurology,University of Medicine and Pharmacy, CraiovaDepartment of Neurology,University of Medicine and Pharmacy, CraiovaDepartment of Informatics and Biostatistics, University of Medicine and Pharmacy, CraiovaGlioblastoma (GB), the most frequent human brain cancer commonly exhibit abberant proliferation and diminished apoptosis.The neoplastic transformation of the glial cells is often related to an overexpression of growth factors and upregulation of their signaling pathways. Insulin-like growth factor 1 (IGF1) and insulin-like growth factor receptor 1 (IGF1R) are often abnormally expressed in GB and seem to be interesting therapeutic targets for GB therapy. This mini-review will focus on IGF1/IGF1R mitogenic pathways. It will also present some inhibitors and antisense targeting IGF1, its receptor and their signaling pathways for GB treatment.https://revistemedicale.amaltea.ro/Romanian_Journal_of_NEUROLOGY/Revista_Romana_de_NEUROLOGIE-2008-Nr.1/RJN_2008_1_Art-01.pdfinsulin-like growth factorigf1rmitogenic pathwaysgbtherapy
collection DOAJ
language English
format Article
sources DOAJ
author Oana Alexandru
Cornelia Zaharia
Valerica Tudoric
D.O. Alexandru
spellingShingle Oana Alexandru
Cornelia Zaharia
Valerica Tudoric
D.O. Alexandru
IGF1/IGF1R MITOGENIC PATHWAYS AND IMPLICATIONS IN GB THERAPY
Romanian Journal of Neurology
insulin-like growth factor
igf1r
mitogenic pathways
gb
therapy
author_facet Oana Alexandru
Cornelia Zaharia
Valerica Tudoric
D.O. Alexandru
author_sort Oana Alexandru
title IGF1/IGF1R MITOGENIC PATHWAYS AND IMPLICATIONS IN GB THERAPY
title_short IGF1/IGF1R MITOGENIC PATHWAYS AND IMPLICATIONS IN GB THERAPY
title_full IGF1/IGF1R MITOGENIC PATHWAYS AND IMPLICATIONS IN GB THERAPY
title_fullStr IGF1/IGF1R MITOGENIC PATHWAYS AND IMPLICATIONS IN GB THERAPY
title_full_unstemmed IGF1/IGF1R MITOGENIC PATHWAYS AND IMPLICATIONS IN GB THERAPY
title_sort igf1/igf1r mitogenic pathways and implications in gb therapy
publisher Amaltea Medical Publishing House
series Romanian Journal of Neurology
issn 1843-8148
2069-6094
publishDate 2008-03-01
description Glioblastoma (GB), the most frequent human brain cancer commonly exhibit abberant proliferation and diminished apoptosis.The neoplastic transformation of the glial cells is often related to an overexpression of growth factors and upregulation of their signaling pathways. Insulin-like growth factor 1 (IGF1) and insulin-like growth factor receptor 1 (IGF1R) are often abnormally expressed in GB and seem to be interesting therapeutic targets for GB therapy. This mini-review will focus on IGF1/IGF1R mitogenic pathways. It will also present some inhibitors and antisense targeting IGF1, its receptor and their signaling pathways for GB treatment.
topic insulin-like growth factor
igf1r
mitogenic pathways
gb
therapy
url https://revistemedicale.amaltea.ro/Romanian_Journal_of_NEUROLOGY/Revista_Romana_de_NEUROLOGIE-2008-Nr.1/RJN_2008_1_Art-01.pdf
work_keys_str_mv AT oanaalexandru igf1igf1rmitogenicpathwaysandimplicationsingbtherapy
AT corneliazaharia igf1igf1rmitogenicpathwaysandimplicationsingbtherapy
AT valericatudoric igf1igf1rmitogenicpathwaysandimplicationsingbtherapy
AT doalexandru igf1igf1rmitogenicpathwaysandimplicationsingbtherapy
_version_ 1724478704778739712